JP2009179634A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009179634A5 JP2009179634A5 JP2009115279A JP2009115279A JP2009179634A5 JP 2009179634 A5 JP2009179634 A5 JP 2009179634A5 JP 2009115279 A JP2009115279 A JP 2009115279A JP 2009115279 A JP2009115279 A JP 2009115279A JP 2009179634 A5 JP2009179634 A5 JP 2009179634A5
- Authority
- JP
- Japan
- Prior art keywords
- escitalopram
- salt
- oxalate
- base
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- WSEQXVZVJXJVFP-FQEVSTJZSA-N escitalopram Chemical compound C1([C@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-FQEVSTJZSA-N 0.000 claims 13
- 229960004341 escitalopram Drugs 0.000 claims 12
- 239000012535 impurity Substances 0.000 claims 7
- 238000000034 method Methods 0.000 claims 7
- 239000002585 base Substances 0.000 claims 5
- 239000012458 free base Substances 0.000 claims 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 5
- WSEQXVZVJXJVFP-HXUWFJFHSA-N (R)-citalopram Chemical compound C1([C@@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-HXUWFJFHSA-N 0.000 claims 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims 4
- WIHMBLDNRMIGDW-BDQAORGHSA-N escitalopram hydrobromide Chemical compound Br.C1([C@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WIHMBLDNRMIGDW-BDQAORGHSA-N 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- KTGRHKOEFSJQNS-BDQAORGHSA-N (1s)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3h-2-benzofuran-5-carbonitrile;oxalic acid Chemical compound OC(=O)C(O)=O.C1([C@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 KTGRHKOEFSJQNS-BDQAORGHSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims 1
- 125000001246 bromo group Chemical group Br* 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 229960005086 escitalopram oxalate Drugs 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 150000003891 oxalate salts Chemical class 0.000 claims 1
- 230000001376 precipitating effect Effects 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200500912 | 2005-06-22 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008517323A Division JP4906852B2 (ja) | 2005-06-22 | 2006-06-22 | エスシタロプラムの結晶質塩基、およびエスシタロプラム塩基を含む口腔内分散性錠剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009179634A JP2009179634A (ja) | 2009-08-13 |
| JP2009179634A5 true JP2009179634A5 (enExample) | 2012-01-19 |
Family
ID=37546630
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008517323A Active JP4906852B2 (ja) | 2005-06-22 | 2006-06-22 | エスシタロプラムの結晶質塩基、およびエスシタロプラム塩基を含む口腔内分散性錠剤 |
| JP2008260742A Active JP4415056B2 (ja) | 2005-06-22 | 2008-10-07 | エスシタロプラムの結晶質塩基、およびエスシタロプラム塩基を含む口腔内分散性錠剤 |
| JP2009115280A Pending JP2009179635A (ja) | 2005-06-22 | 2009-05-12 | エスシタロプラムの結晶質塩基、およびエスシタロプラム塩基を含む口腔内分散性錠剤 |
| JP2009115279A Pending JP2009179634A (ja) | 2005-06-22 | 2009-05-12 | エスシタロプラムの結晶質塩基、およびエスシタロプラム塩基を含む口腔内分散性錠剤 |
| JP2011255804A Active JP5731957B2 (ja) | 2005-06-22 | 2011-11-24 | エスシタロプラムの結晶質塩基、およびエスシタロプラム塩基を含む口腔内分散性錠剤 |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008517323A Active JP4906852B2 (ja) | 2005-06-22 | 2006-06-22 | エスシタロプラムの結晶質塩基、およびエスシタロプラム塩基を含む口腔内分散性錠剤 |
| JP2008260742A Active JP4415056B2 (ja) | 2005-06-22 | 2008-10-07 | エスシタロプラムの結晶質塩基、およびエスシタロプラム塩基を含む口腔内分散性錠剤 |
| JP2009115280A Pending JP2009179635A (ja) | 2005-06-22 | 2009-05-12 | エスシタロプラムの結晶質塩基、およびエスシタロプラム塩基を含む口腔内分散性錠剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011255804A Active JP5731957B2 (ja) | 2005-06-22 | 2011-11-24 | エスシタロプラムの結晶質塩基、およびエスシタロプラム塩基を含む口腔内分散性錠剤 |
Country Status (39)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0123400D0 (en) | 2001-09-28 | 2001-11-21 | Novartis Ag | Organic compounds |
| WO2008059514A2 (en) * | 2006-07-31 | 2008-05-22 | Cadila Healthcare Limited | Process for preparing escitalopram |
| EP2134325A2 (en) * | 2007-03-01 | 2009-12-23 | Aurobindo Pharma Limited | Stable solid dosage forms of an antidepressant |
| ME02391B (me) | 2010-07-23 | 2016-09-20 | H Lundbeck As | Postupak za prečišćavanje farmaceutski prihvatljivih soli escitaloprama |
| CN103360353A (zh) * | 2013-08-07 | 2013-10-23 | 中国药科大学 | 草酸艾司西酞普兰杂质的制备方法 |
| JP2018016569A (ja) * | 2016-07-26 | 2018-02-01 | 株式会社トクヤマ | （１ｓ）−１−［３−（ジメチルアミノ）プロピル］−１−（４−フルオロフェニル）−１，３−ジヒドロイソベンゾフラン−５−カルボニトリル蓚酸塩の製造方法 |
| WO2018190294A1 (ja) * | 2017-04-10 | 2018-10-18 | 東和薬品株式会社 | エスシタロプラム医薬組成物 |
| CN110711198B (zh) * | 2018-07-12 | 2022-03-15 | 山东大学 | D-甘露糖在制备抗抑郁药物中的应用 |
| KR102331187B1 (ko) | 2019-04-09 | 2021-11-26 | 주식회사 라이트팜텍 | 에스시탈로프람을 함유하는 안정성이 우수한 경구용 액제 조성물 및 그의 제조방법 |
| WO2022153262A1 (en) * | 2021-01-18 | 2022-07-21 | Anton Frenkel | Pharmaceutical dosage form |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1526331A (en) | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
| GB8814057D0 (en) | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
| JPH05222041A (ja) * | 1992-02-13 | 1993-08-31 | Mitsubishi Gas Chem Co Inc | アデニン誘導体の精製法 |
| AU680345B2 (en) * | 1994-01-27 | 1997-07-24 | Board Of Regents Of The University Of Oklahoma, The | Rapidly dissolving oral dosage form |
| US5607697A (en) * | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
| DE69717317T2 (de) | 1997-06-30 | 2003-10-02 | Beloit Technologies, Inc. | Verfahren und vorrichtung zum auftragen einer beschichtung auf eine bei hoher geschwindigkeit laufende papierbahn |
| DE69801764T2 (de) | 1997-07-08 | 2002-07-04 | H. Lundbeck A/S, Kobenhavn-Valby | Verfahren zur herstellung von citalopram |
| WO1998019512A2 (en) | 1997-11-11 | 1998-05-14 | H. Lundbeck A/S | Method for the preparation of citalopram |
| FR2785538B1 (fr) * | 1998-11-06 | 2004-04-09 | Prographarm Laboratoires | Comprime a delitement rapide perfectionne |
| US20020071864A1 (en) * | 1999-03-25 | 2002-06-13 | Yuhan Corporation | Rapidly disintegrable tablet for oral administration |
| ITMI991579A1 (it) | 1999-06-25 | 2001-01-15 | Lundbeck & Co As H | Metodo per la preparazione di citalopram |
| ITMI991581A1 (it) | 1999-06-25 | 2001-01-15 | Lundbeck & Co As H | Metodo per la preparazione di citalopram |
| JP2001226372A (ja) * | 1999-12-06 | 2001-08-21 | Sumika Fine Chemicals Co Ltd | ロサルタンの結晶性または結晶化された酸付加塩およびロサルタンの精製方法 |
| GB2357762B (en) * | 2000-03-13 | 2002-01-30 | Lundbeck & Co As H | Crystalline base of citalopram |
| AU2001294192A1 (en) * | 2000-10-06 | 2002-04-22 | Takeda Chemical Industries Ltd. | Solid preparations |
| JP4446463B2 (ja) * | 2000-10-16 | 2010-04-07 | 第一三共株式会社 | 口腔内速崩壊性医薬組成物およびその製造方法 |
| US7799342B2 (en) | 2000-12-06 | 2010-09-21 | Wyeth Llc | Fast dissolving tablet |
| HK1048812B (zh) * | 2000-12-22 | 2007-06-01 | H‧隆德贝克有限公司 | 制备纯西酞普兰的方法 |
| AU3920201A (en) * | 2000-12-28 | 2001-07-09 | H. Lundbeck A/S | Process for the preparation of pure citalopram |
| YU85303A (sh) * | 2001-05-01 | 2006-05-25 | H. Lundbeck A/S | Upotreba enantiomerno čistog escitaloprama |
| US6872405B2 (en) * | 2001-05-10 | 2005-03-29 | Yamanouchi Pharmaceutical Co., Ltd. | Quick-disintegrating tablet in buccal cavity and manufacturing method thereof |
| GB0113842D0 (en) * | 2001-06-07 | 2001-08-01 | Boots Co Plc | Therapeutic agents |
| AR034612A1 (es) * | 2001-06-25 | 2004-03-03 | Lundbeck & Co As H | Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram |
| AR034759A1 (es) | 2001-07-13 | 2004-03-17 | Lundbeck & Co As H | Metodo para la preparacion de escitalopram |
| EP1522539B1 (en) * | 2001-07-31 | 2007-01-24 | H. Lundbeck A/S | Crystalline composition containing escitalopram |
| IS7239A (is) | 2001-12-14 | 2004-04-29 | H. Lundbeck A/S | Aðferð til framleiðslu á essítalóprami |
| WO2003057132A2 (en) * | 2002-01-07 | 2003-07-17 | Sun Pharmaceutical Industries Limited | Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile |
| FR2834889B1 (fr) * | 2002-01-18 | 2004-04-02 | Roquette Freres | Forme pharmaceutique solide orodispersible |
| GB0204607D0 (en) * | 2002-02-27 | 2002-04-10 | Matrix Lab Ltd | Process |
| AU2003225285A1 (en) * | 2002-05-03 | 2003-11-17 | Skyepharma Canada Inc. | Oral dosage forms comprising fenofibrate |
| ATE388947T1 (de) | 2002-12-23 | 2008-03-15 | Lundbeck & Co As H | Escitalopramhydrobromid und ein verfahren zu dessen herstellung |
| CN1510024A (zh) * | 2002-12-24 | 2004-07-07 | 北京德众万全药物技术开发有限公司 | 可用于制备西酞普兰(s)-对映异构体的新的化合物及其制备方法 |
| DE10305984A1 (de) * | 2003-02-13 | 2004-09-02 | Helm Ag | Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen |
| AU2004238321B2 (en) * | 2003-05-07 | 2009-08-27 | Samyang Biopharmaceuticals Corporation | Highly plastic granules for making fast melting tablets |
| WO2005037254A1 (ja) * | 2003-10-15 | 2005-04-28 | Fuji Chemical Industry Co., Ltd. | 口腔内速崩壊性錠剤 |
| AU2003282383A1 (en) * | 2003-11-20 | 2005-06-08 | Natco Pharma Limited | A process for the preparation of high purity escitalopram |
| HU227491B1 (en) * | 2003-11-25 | 2011-07-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Tablet containing citalopram hydrogen bromide |
| CA2558198A1 (en) * | 2004-03-05 | 2005-09-15 | H. Lundbeck A/S | Crystalline composition containing escitalopram oxalate |
| WO2006106531A1 (en) * | 2005-04-04 | 2006-10-12 | Jubilant Organosys Ltd | Process for the preparation of escitalopram or its acid addition salts |
-
2006
- 2006-06-15 TW TW095121358A patent/TWI347942B/zh not_active IP Right Cessation
- 2006-06-15 TW TW100102601A patent/TWI358407B/zh not_active IP Right Cessation
- 2006-06-21 AR ARP060102654A patent/AR055062A1/es not_active Application Discontinuation
- 2006-06-21 MY MYPI20062933A patent/MY143252A/en unknown
- 2006-06-21 MY MYPI2010000618A patent/MY143239A/en unknown
- 2006-06-22 CN CNA2006800200393A patent/CN101189220A/zh active Pending
- 2006-06-22 GB GB0724557A patent/GB2442160B/en not_active Expired - Fee Related
- 2006-06-22 EE EEU200800003U patent/EE00773U1/xx not_active IP Right Cessation
- 2006-06-22 FI FI20080548A patent/FI20080548L/fi unknown
- 2006-06-22 PL PL06742481T patent/PL1896439T5/pl unknown
- 2006-06-22 PL PL384185A patent/PL384185A1/pl unknown
- 2006-06-22 HU HU0800135A patent/HUP0800135A3/hu unknown
- 2006-06-22 DK DK06742481.2T patent/DK1896439T4/en active
- 2006-06-22 SK SK50040-2007A patent/SK500402007A3/sk unknown
- 2006-06-22 KR KR1020127014205A patent/KR20120064140A/ko not_active Ceased
- 2006-06-22 AU AU2006261452A patent/AU2006261452B2/en not_active Withdrawn - After Issue
- 2006-06-22 FI FI20077133A patent/FI20077133L/fi unknown
- 2006-06-22 MX MX2007015328A patent/MX2007015328A/es active IP Right Grant
- 2006-06-22 DE DE112006001619T patent/DE112006001619T5/de not_active Withdrawn
- 2006-06-22 ZA ZA200711066A patent/ZA200711066B/xx unknown
- 2006-06-22 TR TR2007/08792T patent/TR200708792T1/xx unknown
- 2006-06-22 CZ CZ20080429A patent/CZ301286B6/cs not_active IP Right Cessation
- 2006-06-22 KR KR1020107026804A patent/KR20100133023A/ko not_active Ceased
- 2006-06-22 PT PT06742481T patent/PT1896439E/pt unknown
- 2006-06-22 EA EA201001108A patent/EA201001108A1/ru unknown
- 2006-06-22 KR KR1020117005777A patent/KR101340815B1/ko active Active
- 2006-06-22 HR HRP20110093TT patent/HRP20110093T4/hr unknown
- 2006-06-22 EA EA200800102A patent/EA019239B1/ru not_active IP Right Cessation
- 2006-06-22 CA CA2612827A patent/CA2612827C/en not_active Expired - Fee Related
- 2006-06-22 TR TR2010/00625T patent/TR201000625T1/xx unknown
- 2006-06-22 SI SI200630923T patent/SI1896439T2/sl unknown
- 2006-06-22 CA CA002646780A patent/CA2646780A1/en not_active Abandoned
- 2006-06-22 WO PCT/DK2006/000366 patent/WO2006136169A2/en not_active Ceased
- 2006-06-22 EP EP06742481.2A patent/EP1896439B2/en active Active
- 2006-06-22 SG SG201100648-3A patent/SG169358A1/en unknown
- 2006-06-22 CN CN201010286088XA patent/CN101928269A/zh active Pending
- 2006-06-22 UA UAA200800362A patent/UA86536C2/ru unknown
- 2006-06-22 JP JP2008517323A patent/JP4906852B2/ja active Active
- 2006-06-22 CZ CZ20070898A patent/CZ299906B6/cs not_active IP Right Cessation
- 2006-06-22 ES ES200750085A patent/ES2319073B1/es not_active Expired - Fee Related
- 2006-06-22 EP EP10179395A patent/EP2325177A1/en not_active Withdrawn
- 2006-06-22 GB GB0811164A patent/GB2448834B/en not_active Expired - Fee Related
- 2006-06-22 KR KR1020117015711A patent/KR20110084341A/ko not_active Ceased
- 2006-06-22 BR BRPI0612295-7A patent/BRPI0612295A2/pt not_active IP Right Cessation
- 2006-06-22 KR KR1020077028918A patent/KR20080018191A/ko not_active Ceased
- 2006-06-22 AT AT0900506U patent/AT10983U1/de not_active IP Right Cessation
- 2006-06-22 CZ CZ20080430A patent/CZ300686B6/cs not_active IP Right Cessation
- 2006-06-22 DE DE602006019961T patent/DE602006019961D1/de active Active
- 2006-06-22 AT AT06742481T patent/ATE497500T1/de active
- 2006-06-22 RS RS20110057A patent/RS51575B2/sr unknown
- 2006-06-22 ES ES06742481.2T patent/ES2356838T5/es active Active
- 2006-06-22 EP EP10179318A patent/EP2385044A1/en not_active Withdrawn
-
2007
- 2007-11-18 IL IL187454A patent/IL187454A0/en unknown
- 2007-12-19 BG BG10110024A patent/BG66086B1/bg unknown
- 2007-12-21 LV LVP-07-157A patent/LV13677B/lv unknown
-
2008
- 2008-01-14 IS IS8705A patent/IS8705A/is unknown
- 2008-01-18 NO NO20080359A patent/NO20080359L/no unknown
- 2008-01-21 DK DK200800075A patent/DK200800075A/da not_active Application Discontinuation
- 2008-01-21 LT LT2008005A patent/LT5550B/lt not_active IP Right Cessation
- 2008-10-07 JP JP2008260742A patent/JP4415056B2/ja active Active
-
2009
- 2009-02-27 DK DKPA200900284A patent/DK200900284A/da not_active Application Discontinuation
- 2009-03-10 ZA ZA200901698A patent/ZA200901698B/en unknown
- 2009-05-12 JP JP2009115280A patent/JP2009179635A/ja active Pending
- 2009-05-12 JP JP2009115279A patent/JP2009179634A/ja active Pending
- 2009-07-07 AT AT0041709U patent/AT11883U1/de not_active IP Right Cessation
-
2010
- 2010-03-05 AU AU2010200844A patent/AU2010200844A1/en not_active Withdrawn
- 2010-12-20 NO NO20101777A patent/NO20101777L/no not_active Application Discontinuation
- 2010-12-27 AR ARP100104958A patent/AR079750A2/es not_active Application Discontinuation
-
2011
- 2011-02-03 CY CY20111100116T patent/CY1112392T1/el unknown
- 2011-11-24 JP JP2011255804A patent/JP5731957B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009179634A5 (enExample) | ||
| JP2006519255A5 (enExample) | ||
| JP2009138000A5 (enExample) | ||
| JP2019147825A5 (enExample) | ||
| JP2018502909A5 (enExample) | ||
| CN1227233C (zh) | 纯晶形的5－氯－3－(4－甲磺酰基苯基)－6′－甲基－[2,3′]联吡啶及其合成方法 | |
| JP2014501282A5 (enExample) | ||
| JP2012233154A5 (enExample) | ||
| JP2011157386A5 (enExample) | ||
| JP2014503001A5 (enExample) | ||
| JP2005520923A5 (enExample) | ||
| JP2018528948A5 (enExample) | ||
| JP2019524752A5 (enExample) | ||
| JP2012508747A5 (enExample) | ||
| JP2018009003A5 (enExample) | ||
| JP2005502603A5 (enExample) | ||
| CN103443084A (zh) | 制备苯达莫司汀的方法 | |
| JP2008247919A5 (enExample) | ||
| HRP20110093T1 (hr) | Kristalna baza escitaloprama i orodisperzibilne tablete koje sadrže bazu escitaloprama | |
| US9815801B2 (en) | Method of refining valsartan comprising more than or equal to 10% D-isomers | |
| JP2011529050A5 (enExample) | ||
| JP2010504367A5 (enExample) | ||
| JP2015535210A5 (enExample) | ||
| JP2007045816A5 (ja) | カルバゾール誘導体、発光素子用材料として用いられるアントラセン誘導体の作製方法 | |
| CN104703967B (zh) | 氟伏沙明游离碱的精制方法及利用其的高纯度马来酸氟伏沙明的制备方法 |